NO20043323L - Selektiv enzymatisk forestring og solvolyse av epimerisk vitamin D-analog og separasjon av epimerene - Google Patents

Selektiv enzymatisk forestring og solvolyse av epimerisk vitamin D-analog og separasjon av epimerene

Info

Publication number
NO20043323L
NO20043323L NO20043323A NO20043323A NO20043323L NO 20043323 L NO20043323 L NO 20043323L NO 20043323 A NO20043323 A NO 20043323A NO 20043323 A NO20043323 A NO 20043323A NO 20043323 L NO20043323 L NO 20043323L
Authority
NO
Norway
Prior art keywords
epimers
analog
solvolysis
separation
enzymatic esterification
Prior art date
Application number
NO20043323A
Other languages
English (en)
Inventor
Evgeny Shapiro
Anchel Schwartz
Ayelet Fishman
Reinhard Effenberger
Asher Maymon
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20043323L publication Critical patent/NO20043323L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/18—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20043323A 2002-01-10 2004-08-10 Selektiv enzymatisk forestring og solvolyse av epimerisk vitamin D-analog og separasjon av epimerene NO20043323L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34808202P 2002-01-10 2002-01-10
US34997702P 2002-01-18 2002-01-18
PCT/US2003/000623 WO2003060094A2 (en) 2002-01-10 2003-01-09 Selective enzymatic esterification and solvolysis of epimeric vitamin d analog and separation of the epimers

Publications (1)

Publication Number Publication Date
NO20043323L true NO20043323L (no) 2004-08-10

Family

ID=26995556

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043323A NO20043323L (no) 2002-01-10 2004-08-10 Selektiv enzymatisk forestring og solvolyse av epimerisk vitamin D-analog og separasjon av epimerene

Country Status (15)

Country Link
US (1) US8129173B2 (no)
EP (1) EP1470220B1 (no)
JP (1) JP2005514929A (no)
KR (1) KR100630859B1 (no)
CN (1) CN1639329A (no)
AT (1) ATE527372T1 (no)
AU (1) AU2003210473A1 (no)
CA (1) CA2472178A1 (no)
HR (1) HRP20040674A2 (no)
IL (1) IL162920A0 (no)
IS (1) IS7347A (no)
MX (1) MXPA04006741A (no)
NO (1) NO20043323L (no)
PL (1) PL373677A1 (no)
WO (1) WO2003060094A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
AU2003275987A1 (en) 2002-06-13 2003-12-31 Teva Pharmaceutical Industries Ltd. Epimerization of analogs of vitamin d
US7351869B2 (en) 2002-11-18 2008-04-01 Teva Pharmaceutical Industries Ltd Crystallization method for purification of calcipotriene
US8362287B2 (en) 2004-03-18 2013-01-29 Leo Pharma A/S Stereoselective synthesis of vitamin D analogues
PL207034B1 (pl) 2004-12-30 2010-10-29 Inst Farmaceutyczny Sposób wytwarzania bezwodnego kalcypotriolu
EP2526930B1 (en) 2005-06-01 2013-12-25 GlaxoSmithKline Intellectual Property Development Limited Vitamin formulation
TW200643172A (en) * 2005-06-01 2006-12-16 Formosa Lab Inc Selective enzymatic esterfication and solvolysis of epimeric vitamin D analog and separation and epimerization of the epimers
CN100404686C (zh) * 2005-06-10 2008-07-23 台耀化学股份有限公司 维生素d衍生物异构物的分离及异构化的方法
CN101906443B (zh) * 2010-06-25 2012-07-25 绍兴文理学院 (2S)-[2-(t-叔丁基)二甲基硅氧基]-2-环丙基-1-乙基-三苯基膦的合成方法
US9119528B2 (en) 2012-10-30 2015-09-01 Dexcom, Inc. Systems and methods for providing sensitive and specific alarms
CN103694156B (zh) * 2014-01-07 2015-09-02 成都医路康医学技术服务有限公司 一种银屑病治疗药物钙泊三醇的制备方法
CN104830943B (zh) * 2015-03-18 2019-03-01 上海皓元生物医药科技有限公司 一种艾尔骨化醇中间体的制备方法
CN106188122B (zh) * 2015-05-05 2019-05-14 上海医药工业研究院 一种手性烯丙醇类化合物的差向异构化方法
US11358143B2 (en) 2019-03-19 2022-06-14 Siemens Healthcare Diagnostics Inc. Compositions, devices, and methods of mitigating lipoprotein interference in in vitro diagnostic assays for hydrophobic analytes

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4594340A (en) 1984-11-29 1986-06-10 Hoffmann-La Roche Inc. 25,26-dehydro-1α,24R-dihydroxycholecalciferol and 25,26-dehydro-1α,24S-dihydroxycholecalciferol and the epimeric mixture
JPH07100685B2 (ja) * 1985-08-02 1995-11-01 レオ・ファ−マシュ−ティカル・プロダクツ・リミテッド・エイ／エス（レ−ベンス・ケミスケ・ファブリック・プロデュクチオンスアクチ−セルスカブ） 新規ビタミンｄ類似体
DE3743824C2 (de) * 1987-12-23 1997-03-06 Hoechst Ag Verfahren zur enzymatischen Racematspaltung von racemischen Alkoholen mit/in Vinylestern durch Umesterung
US4996158A (en) * 1987-12-26 1991-02-26 Junichi Oda Optical resolution of racemic alcohols
US5401731A (en) 1989-06-29 1995-03-28 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Productionsaktieselskab) Vitamin D analogues
DE3933034A1 (de) 1989-10-02 1991-04-11 Schering Ag 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung
DE69123402T2 (de) 1990-08-13 1997-04-03 Suntory Ltd Verfahren zur Herstellung optisch aktiver Alpha-Hydroxyalkenderivate
AU1247592A (en) 1991-01-08 1992-08-17 Lunar Corporation Methods for preparation and use of 1alpha,24-dihydroxy vitamin d2
US5789397A (en) 1991-01-08 1998-08-04 Bone Care International, Inc. Methods for preparation and use of 1A,24(S)-dihydroxy vitamin D2
US5413935A (en) * 1991-04-24 1995-05-09 E. R. Squibb & Sons, Inc. Process for selecting an enantiomer of a hydroxy lactone using pseudomonas lipase
US6262283B1 (en) 1996-12-06 2001-07-17 Magainin Pharmaceuticals Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
JPH11130711A (ja) 1997-10-24 1999-05-18 Teijin Ltd １α，２４，２５−トリヒドロキシビタミンＤ３類の合成中間体およびその製造法
US6531459B1 (en) 1997-12-17 2003-03-11 Schering Aktiengesellschaft Vitamin D derivatives with phosphorus atoms in the side chains
GB9908327D0 (en) 1999-04-12 1999-06-09 Chirotech Technology Ltd Process for the preparation of prostaglandin precursors
US6362350B1 (en) 1999-07-01 2002-03-26 Wisconsin Alumni Research Foundation Crystalline 1α, 24(S)-dihydroxyvitamin D2 and method of purification thereof
JP2001204484A (ja) 2000-01-20 2001-07-31 Eisai Co Ltd 酵素を用いる光学活性体の製造法
NL1015313C2 (nl) 2000-05-26 2001-11-27 Dsm Nv Werkwijze voor de bereiding van enantiomeer verrijkte esters en alcoholen.
AU2003275987A1 (en) 2002-06-13 2003-12-31 Teva Pharmaceutical Industries Ltd. Epimerization of analogs of vitamin d

Also Published As

Publication number Publication date
KR100630859B1 (ko) 2006-10-04
CN1639329A (zh) 2005-07-13
HRP20040674A2 (en) 2005-06-30
EP1470220B1 (en) 2011-10-05
AU2003210473A1 (en) 2003-07-30
US8129173B2 (en) 2012-03-06
IL162920A0 (en) 2005-11-20
MXPA04006741A (es) 2006-05-31
WO2003060094A3 (en) 2003-12-24
JP2005514929A (ja) 2005-05-26
EP1470220A4 (en) 2007-12-05
PL373677A1 (en) 2005-09-05
EP1470220A2 (en) 2004-10-27
CA2472178A1 (en) 2003-07-24
ATE527372T1 (de) 2011-10-15
IS7347A (is) 2004-07-07
KR20040081122A (ko) 2004-09-20
US20030166226A1 (en) 2003-09-04
WO2003060094A2 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
NO20043323L (no) Selektiv enzymatisk forestring og solvolyse av epimerisk vitamin D-analog og separasjon av epimerene
EP1947189A3 (en) Method of vitamin production
ATE204757T1 (de) Verwendung von piperine zur verbesserung der gastrointestinalen absorption
BR0311930A (pt) Processo para a produção de água purificada a partir da água de reação de fischer-tropsch
ATE305296T1 (de) Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrung
DE60300273D1 (de) Verbessertes Verfahren für die Herstellung von Methacrylsäure und Methacrylsäureester
MY128271A (en) Purification method for (meth) acrylic acid
UA43333C2 (uk) Спосіб очищення 10-дезацетилбаккатину ііі та таксотеру
AU2002354696A1 (en) Method for purifying an enzyme, a purified enzyme produced thereby, and use of this enzyme
AU2003283391A1 (en) Voice processing system, method for allocating acoustic and/or written character strings to words or lexical entries
WO2001040177A3 (en) Esters of vitamin d3 and uses thereof
ATE363540T1 (de) Enzymatische herstellung von (meth)acrylsäureestern
IS6034A (is) Aðferð til að einangra Pseudomonas sýru A úr ræktunarseyði sem inniheldur Pseudomonas sýrukomplex
NO20023276D0 (no) Fremgangsmåte til å fremstille betulinsyre
AU6381900A (en) Chemiluminescent substrates of hydrolytic enzymes such as phosphatases
DE50312796D1 (de) Verfahren zur herstellung von isocyanaten
AR005995A1 (es) Procedimiento para la purificación de proteasas similares a trombina a partir de venenos de serpiente.
AR027327A1 (es) Procedimiento para la separacion einzimatica de racematos de derivados de aminometil-aril-ciclohezanol
HRP20030356A2 (en) Process for enzymatic production of enantiomer-enriched -amino acids
WO2001061329A3 (en) Method for isolating a proportion of a fluid mixture
AU2001295460A1 (en) Method for producing an air separation installation
NO20001404D0 (no) Nye stereoselektive fremgangsmåter for fremstilling av gabapentinanaloger
WO2003042236A1 (fr) Procede de fabrication de proteines concentrees/epurees a l'aide d'une composition minerale d'argile
BR9901234A (pt) Processo e aparelhagem para a produçào de argÈnio.
PL376973A1 (pl) Sposób oczyszczania monoazotanu 1,4-butanodiolu

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application